Advertisement

Arthritic Conditions Affecting the Temporomandibular Joint

  • L. G. MercuriEmail author
  • S. Abramowicz
Reference work entry

Abstract

Arthritis is the most common inflammatory joint disease in children and adults. It has multifactorial etiology resulting in joint degeneration and loss of function. Using a management classification scheme based on clinical signs, symptoms, and imaging, this chapter will present an evidence-based discussion for the management of arthritic conditions affecting the temporomandibular joint (TMJ). The common and significant signs and symptoms of TMJ arthritic conditions are pain, loss of joint function, joint instability, mandibular dysfunction, and facial deformity due to loss of posterior mandibular vertical dimension, as pathologic osteolysis decreases the height of the condyle. Medical management can ameliorate early-stage disease. Progressive disease may require the employment of invasive procedures, whereas in end-stage disease, joint replacement is typically required.

Keywords

Temporomandibular joint Arthritis Osteoarthritis Degenerative joint disease TMJ reconstruction TMJ replacement Rheumatoid arthritis Juvenile idiopathic arthritis Arthrocentesis Arthroscopy Orthognathic surgery Synovectomy 

References

  1. Abramowicz S, Cheon J, Kim S, Bacic J, Lee EY. Magnetic resonance imaging of temporomandibular joints in children with arthritis. J Oral Maxillofac Surg. 2011;69:2321–8.PubMedCrossRefGoogle Scholar
  2. Abramowicz S, Susarla HK, Kim S, Kaban LB. Physical findings associated with active temporomandibular joint inflammation in children with juvenile idiopathic arthritis. J Oral Maxillofac Surg. 2013a;71:1683–7.PubMedCrossRefGoogle Scholar
  3. Abramowicz S, Kim S, Susarla HK, Kaban LB. Differentiating arthritic from myofascial pain in children with juvenile idiopathic arthritis: preliminary report. J Oral Maxillofac Surg. 2013b;71:493–6.PubMedCrossRefGoogle Scholar
  4. Abramowicz S, Kim S, Prahalad S, Chouinard AF, Kaban LB. Juvenile arthritis: current concepts in terminology, etiopathogenesis, diagnosis, and management. Int J Oral Maxillofac Surg. 2016;45:801–12.PubMedCrossRefGoogle Scholar
  5. Alpaslan GH, Alpaslan C. Efficacy of temporomandibular joint arthrocentesis with and without injection of sodium hyaluronate in treatment of internal derangements. J Oral Maxillofac Surg. 2001;59:613–8.PubMedCrossRefGoogle Scholar
  6. American Academy of Orthopaedic Surgeons. Treatment of osteoarthritis of the knee. 2nd ed. Rosemont: American Academy of Orthopaedic Surgeons; 2013.Google Scholar
  7. Arabshahi B, Dewitt EM, Cahill AM, Kaye RD, Baskin KM, Towbin RB, Cron RQ. Utility of corticosteroid injection for temporomandibular arthritis in children with juvenile idiopathic arthritis. Arthritis Rheum. 2005;52:3563–9.PubMedCrossRefGoogle Scholar
  8. Arnett GW, Gunson MJ. Risk factors in the initiation of condylar resorption. Semin Orthod. 2013;19:81–8.CrossRefGoogle Scholar
  9. Arora P, Amarnath J, Ravindra SV, Rallan M. Temporomandibular joint involvement in ankylosing spondylitis. BMJ Case Rep. 2013;2013:bcr2013009386.PubMedPubMedCentralGoogle Scholar
  10. Bays AM, Gardner G. Pharmacologic therapies for rheumatologic and autoimmune conditions. Med Clin N Am. 2016;100:719–31.PubMedCrossRefGoogle Scholar
  11. Beaulieu AD, Peloso PM, Haraoui B, Bensen W, Thomson G, Wade J, Quigley P, Eisenhoffer J, Harsanyi Z, Darke AC. Once-daily, controlled-release tramadol and sustained-release diclofenac relieve chronic pain due to osteoarthritis: a randomized controlled trial. Pain Res Manag. 2008;13:103–10.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Bertalomi CN, Gay T, Clark GT, Rendell J, Shetty V, Liu C, Swann DA. Use of sodium hyaluronate in treating temporomandibular joint disorders: a randomized, double-blind, placebo-controlled clinical trial. J Oral Maxillofac Surg. 1993;51:232–42.CrossRefGoogle Scholar
  13. Bjornland T, Larheim TA. Synovectomy and discectomy of the temporomandibular joint in patients with arthritic disease compared with discectomy in patients with internal derangement. A 3-year follow-up study. Eur J Oral Sci. 1995;103:2–7.PubMedCrossRefGoogle Scholar
  14. Bongartz T, Halligan CS, Osmon DR, Reinalda MS, Bamlet WR, Crowson CS, Hanssen AD, Matteson EL. Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum. 2008;59:1713–20.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Bouloux GF. Use of opioids in long-term management of temporomandibular joint dysfunction. J Oral Maxillofac Surg. 2011;69:1885–91.PubMedCrossRefGoogle Scholar
  16. Brooks SL, Westesson PL, Eriksson L, Hansson LG, Barsotti JB. Prevalence of osseous changes in the temporomandibular joint of asymptomatic persons without internal derangement. Oral Surg Oral Med Oral Pathol. 1992;73:118–22.PubMedCrossRefGoogle Scholar
  17. Browning SR, Weiser AM, Woolf N, Golish SR, SanGiovanni TP, Scuderi GJ, Carballo C, Hanna LS. Platelet-rich plasma increases matrix metalloproteinases in cultures of human synovial fibroblasts. J Bone Joint Surg Am. 2012;94:e1721–7.PubMedCrossRefGoogle Scholar
  18. Campos MI, Campos PS, Cangussu MC, Guimarães RC, Line SR. Analysis of magnetic resonance imaging characteristics and pain in temporomandibular joints with and without degenerative changes of the condyle. Int J Oral Maxillofac Surg. 2008;37:329–34.CrossRefGoogle Scholar
  19. Casares G, Thomas A, Carmona J, Acero J, Vila CN. Influence of oral stabilization appliances in intra-articular pressure of the temporomandibular joint. Cranio. 2014;32:219–23.PubMedCrossRefGoogle Scholar
  20. Chandler GN, Wright V. Deleterious effect of intra-articular hydrocortisone. Lancet. 1958;2:661–3.PubMedCrossRefGoogle Scholar
  21. Chevalier X, Goupille P, Beaulieu AD, Burch FX, Bensen WG, Conrozier T, Loeuille D, Kivitz AJ, Silver D, Appleton BE. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double blind, placebo-controlled study. Arthritis Rheum. 2009;61:344–52.PubMedCrossRefGoogle Scholar
  22. Cohen SB, Proudman S, Kivitz AJ, Burch FX, Donohue JP, Burstein D, Sun YN, Banfield C, Vincent MS, Ni L, Zack DJ. A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther. 2011;13:R125.PubMedPubMedCentralCrossRefGoogle Scholar
  23. Crincoli V, Di Comite M, Di Bisceglie MB, Fatone L, Favia G. Temporomandibular disorders in psoriasis patients with and without psoriatic arthritis: an observational study. Int J Med Sci. 2015;12:341–8.PubMedPubMedCentralCrossRefGoogle Scholar
  24. de Souza RF, Lovato da Silva CH, Nasser M, Fedorowicz Z, Al-Muharraqi MA. Interventions for the management of temporomandibular joint osteoarthritis. Cochrane Database Syst Rev. 2012;18(4):CD007261. doi:10.1002/14651858.CD007261.pub2.CrossRefGoogle Scholar
  25. DeClercq CA, Neyt LF, Mommaerts MY, Abeloos JV, De Mot BM. Condylar resorption in orthognathic surgery: a retrospective study. Int J Adult Orthod Orthognath Surg. 1994;9:233–40.Google Scholar
  26. Detamore MS, Athanasiou KA, Mao J. A call to action for bioengineers and dental professionals: directives for the future of TMJ bioengineering. Ann Biomed Eng. 2007;35:1301–11.PubMedCrossRefGoogle Scholar
  27. Dingman RO, Grabb WC. Intra-capsular temporomandibular joint arthroplasty. Plast Reconstr Surg. 1966;38:179–85.PubMedCrossRefGoogle Scholar
  28. Felson DT. Clinical practice. osteoarthritis of the knee. N Engl J Med. 2006;354:841–8.PubMedCrossRefGoogle Scholar
  29. Frietas RZ, Mehra P, Wolford LM. Autogenous versus alloplastic TMJ reconstruction in rheumatoid-induced TMJ disease. J Oral Maxillofac Surg. 2002;58(Suppl 1):43.Google Scholar
  30. Garcia RL, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343:769–72.CrossRefGoogle Scholar
  31. Gayle EA, Young SM, McKenna SJ, McNaughton CD. Septic arthritis of the temporomandibular joint: case reports and review of the literature. J Emerg Med. 2013;45:674–8.PubMedPubMedCentralCrossRefGoogle Scholar
  32. Gerwin N, Hops C, Lucke A. Intraarticular drug delivery in osteoarthritis. Adv Drug Deliv Rev. 2006;58:226–42.PubMedCrossRefGoogle Scholar
  33. Gunson MJ, Arnett GW, Formby B, Falzone C, Mathur R, Alexander C. Oral contraceptive pill use and abnormal menstrual cycles in women with severe condylar resorption: a case for low serum 17 beta-estradiol as a major factor in progressive condylar resorption. Am J Orthod Dentofac Orthop. 2009;136:772–9.CrossRefGoogle Scholar
  34. Gynther GW, Holmlund AB. Efficacy of arthroscopic lysis and lavage in patients with temporomandibular joint symptoms associated with generalized osteoarthritis or rheumatoid arthritis. J Oral Maxillofac Surg. 1998;56:147–51.PubMedCrossRefGoogle Scholar
  35. Handleman CS, Mercuri LG. Chapter 7: Idiopathic/progressive condylar resorption: an orthodontic perspective. In: Kandasamy S, editor. TMD and orthodontics – a clinical guide for the orthodontist. New York: Springer; 2015.Google Scholar
  36. Hatcher DC. Progressive condylar resorption: pathologic processes and imaging considerations. Semin Orthod. 2013;19:97–105.CrossRefGoogle Scholar
  37. Hébert-Blouin MN, Tubbs RS, Carmichael SW, Spinner RJ. Hilton’s law revisited. Clin Anat. 2014;27:548–55.PubMedCrossRefGoogle Scholar
  38. Heffez LB. Arthroscopy. In: Kaplan AS, Assael LA, editors. Temporomandibular disorders: diagnosis and treatment. Philadelphia: Saunders; 1991. p. 628–62.Google Scholar
  39. Hegab AF, Ali HE, Elmasry M, Khallaf MG. Platelet-rich plasma injection as an effective treatment for temporomandibular joint osteoarthritis. J Oral Maxillofac Surg. 2015;73:1706–13.PubMedCrossRefGoogle Scholar
  40. Henderson SE, Lowe JR, Tudares MA, Gold MS, Almarza AJ. Temporomandibular joint fibrocartilage degeneration from unilateral dental splints. Arch Oral Biol. 2015;60:1–11.PubMedCrossRefGoogle Scholar
  41. Henny FA, Baldridge OL. Condylectomy for the persistently painful temporomandibular joint. J Oral Surg. 1957;15:24–31.PubMedGoogle Scholar
  42. Herberts P, Ahnfelt L, Malchau H, Strömberg C, Andersson GB. J. Multicenter clinical trials and their value in assessing total joint arthroplasty. Clin Orthop. 1989;249:48–55.Google Scholar
  43. Hochberg MC. Osteoarthritis: the rheumatologist’s perspective. HSSJ. 2012;8:35–6.CrossRefGoogle Scholar
  44. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P, American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64:465–74.CrossRefGoogle Scholar
  45. Hollander J. Intra-articular hydrocortisone in arthritis and allied conditions. J Bone Joint Surg Am. 1953;35:983–90.PubMedCrossRefGoogle Scholar
  46. Holmlund A. Connective tissue pathology: Arthridities. In: Thomas M, Bronstein S, editors. Arthroscopy of the Temporomandibular Joint. Philadelphia: WB Saunders; 1991. p. 276–81.Google Scholar
  47. Holmlund A, Hellsing G, Wredmark T. Arthroscopy of the temporomandibular joint: a clinical study. Int J Oral Maxillofac Surg. 1986;15:715–21.PubMedCrossRefGoogle Scholar
  48. Hootman JL, Helmick CG. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum. 2006;54:226–9.PubMedCrossRefGoogle Scholar
  49. Israel HA, Saed-Nejad F, Ratcliffe A. Early diagnosis of osteoarthrosis of the temporomandibular joint: correlation between arthroscopic diagnosis and keratin sulfate levels in the synovial fluid. J Oral Maxillofac Surg. 1991;49:708–11.PubMedCrossRefGoogle Scholar
  50. Jackson DW, Evans NA, Thomas BM. Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am. 2002;84-A:1522–7.PubMedCrossRefGoogle Scholar
  51. Jayson MIV, Dison AL. Arthroscopy of the knee in rheumatoid disease. Ann Rheum Dis. 1968;27:503–11.PubMedPubMedCentralCrossRefGoogle Scholar
  52. Jones A, Regan M, Ledingham J, Pattrick M, Manhire A, Doherty M. Importance of placement of intra-articular steroid injections. BMJ. 1993;307:1329–30.PubMedPubMedCentralCrossRefGoogle Scholar
  53. Jordan N, D’Cruz D. Current and emerging treatment options in the management of lupus. Immunotargets Ther. 2016;5:9–20.PubMedPubMedCentralCrossRefGoogle Scholar
  54. Kahlenberg JM, Fox DA. Advances in the medical treatment of rheumatoid arthritis. Hand Clin. 2011;27:11–20.PubMedPubMedCentralCrossRefGoogle Scholar
  55. Kent JN, Misiek DJ. Controversies in disc condyle replacement for partial and total temporomandibular joint reconstruction. In: Worthington P, Evans JR, editors. Controversies in oral and maxillofacial surgery. Philadelphia: WB Saunders; 1994. p. 397–435.Google Scholar
  56. Kent JN, Carlton DM, Zide MF. Rheumatoid disease and related arthropathies. II – Surgical rehabilitation of the temporomandibular joint. Oral Surg. 1986;61:423–39.PubMedCrossRefGoogle Scholar
  57. Kerstens HC, Tuinzing DB, Golding RP, van der Kwast WA. Condylar atrophy and osteoarthrosis after bimaxillary surgery. Oral Surg. 1990;69:274–80.PubMedCrossRefGoogle Scholar
  58. Kiliç SC. Does injection of corticosteroid after arthrocentesis improve outcomes of temporomandibular joint osteoarthritis? A randomized clinical trial. J Oral Maxillofac Surg. 2016;74:2151–8.CrossRefGoogle Scholar
  59. Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, Cenacchi A, Fornasari PM, Giannini S, Marcacci M. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc. 2010;18:472–9.PubMedCrossRefGoogle Scholar
  60. Kopp S, Carlsson GE, Haraldson T, Wenneberg B. Long-term effect of intra-articular injections of sodium hyaluronate and corticosteroids on temporomandibular joint arthritis. J Oral Maxillofac Surg. 1987;45:929–35.PubMedCrossRefGoogle Scholar
  61. Kütük N, Baş B, Soylu E, Gönen ZB, Yilmaz C, Balcioğlu E, Özdamar S, Alkan A. Effect of platelet-rich plasma on fibrocartilage, cartilage, and bone repair in temporomandibular joint. J Oral Maxillofac Surg. 2014;72:277–84.PubMedCrossRefGoogle Scholar
  62. Lane NE, Schnitzer TJ, Birbara CA, Mokhtarani M, Shelton DL, Smith MD, Brown MT. Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med. 2010;363:1521–31.PubMedCrossRefGoogle Scholar
  63. Larsen C, Ostergaard J, Larsen SW, Jensen H, Jacobsen S, Lindegaard C, Andersen PH. Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. J Pharm Sci. 2008;97:4622–54.PubMedCrossRefGoogle Scholar
  64. Laviv A, Sadow PM, Keith DA. Pseudogout in the temporomandibular joint with imaging, arthroscopic, operative, and pathologic findings. Report of an unusual case. J Oral Maxillofac Surg. 2015;73:1106–12.PubMedCrossRefGoogle Scholar
  65. Leandro LF, Ono HY, Loureiro CC, Marinho K, Guevara HA. A 10-year experience and follow-up of 300 patients fitted with the Biomet/Lorenz Microfixation TMJ replacement system. Int J Oral Maxillofac Surg. 2013;42:1007–13.PubMedCrossRefGoogle Scholar
  66. Lindqvist C, Jokinen J, Paukku P, Tasanen A. Adaptation of autogenous costochondral grafts used for temporomandibular joint reconstruction: a long-term clinical and radiologic follow-up. J Oral Maxillofac Surg. 1988;46:465–70.PubMedCrossRefGoogle Scholar
  67. Lohmander LS, Hellot S, Dreher D, Krantz EF, Kruger DS, Guermazi A, Eckstein F. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2014;66:1820–31.CrossRefGoogle Scholar
  68. Ma MHY, Kingsley GH, Scott DL. A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis. Rheumatology. 2010;49:91–8.PubMedCrossRefGoogle Scholar
  69. MacIntosh RB. Current spectrum of costochondral and dermal grafting. In: Bell WH, editor. Modern practice in orthognathic and reconstructive surgery, vol. 2. Philadelphia: WB Saunders; 1992. p. 904–49.Google Scholar
  70. MacIntosh RB. The case for autogenous reconstruction of the adult temporomandibular joint. In: Worthington P, Evans JR, editors. Controversies in oral and maxillofacial surgery. Philadelphia: WB Saunders; 1994. p. 356–80.Google Scholar
  71. MacIntosh RB. The use of autogenous tissue in temporomandibular joint reconstruction. J Oral Maxillofac Surg. 2000;58:63–9.PubMedCrossRefGoogle Scholar
  72. Manfredini D, Bonnini S, Arboretti R, Guarda-Nardini L. Temporomandibular joint osteoarthritis: an open label trial of 76 patients treated with arthrocentesis plus hyaluronic acid injections. Int J Oral Maxillofac Surg. 2009;38:827–34.PubMedCrossRefGoogle Scholar
  73. Mansour AM, Jaroudi MO, Medawar WA, Tabbarah ZA. Bilateral multifocal posterior pole lesions in Reiter syndrome. BMJ Case Rep. 2013;2013:bcr2013009253.PubMedPubMedCentralCrossRefGoogle Scholar
  74. Mehra P, Wolford LM. Custom-made TMJ reconstruction and simultaneous mandibular advancement in autoimmune/connective tissue diseases. J Oral Maxillofac Surg. 2000;58(Suppl 1):95.Google Scholar
  75. Mehra P, Nadershah M, Chigurupati R. Is alloplastic temporomandibular joint reconstruction a viable option in the surgical management of adult patients with idiopathic condylar resorption? J Oral Maxillofac Surg. 2016;74:2044–54.PubMedCrossRefGoogle Scholar
  76. Mejersjö C, Hollender L. Radiography of the temporomandibular joint in female patients with TMJ pain or dysfunction. Acta Radiol Diagn. 1984;25:169–76.CrossRefGoogle Scholar
  77. Mercuri LG. Surgical management of TMJ arthritis. In: Laskin DM, Green CS, Hylander WL, editors. Temporomandibular joint disorders: an evidence-based approach to diagnosis and treatment. Chicago: Quintessence; 2006. p. 455–68.Google Scholar
  78. Mercuri LG. A rationale for total alloplastic temporomandibular joint reconstruction in the management of idiopathic/progressive condylar resorption. J Oral Maxillofac Surg. 2007;65:1600–9.PubMedCrossRefGoogle Scholar
  79. Mercuri LG. End-stage TMD and TMJ reconstruction. In: Miloro M, Ghali G, Larsen P, Waite P, editors. Peterson’s principles of oral & maxillofacial surgery, vol. 52. 3rd ed. Ipswich: PMPH, USA Ltd.; 2012. p. 1173–86.Google Scholar
  80. Michelotti A, Altergren P, Goulet JP, Lobbezoo F, Ohrbach R, Peck C, Schiffman E, List T. Next steps in development of the diagnostic criteria for temporomandibular joint disorders (DC/TMD): recommendations from the International RDC/TMD Consortium workshop. J Oral Rehabil. 2016;43:453–67.PubMedCrossRefGoogle Scholar
  81. Mishima K, Yamada T, Sugahara T. Evaluation of respiratory status and mandibular movement after total temporomandibular joint replacement in patients with rheumatoid arthritis. Int J Oral Maxillofac Surg. 2003;32:275–9.PubMedCrossRefGoogle Scholar
  82. Moore KG, Gooris PJ, Stoelinga PJ. The contributing role of condylar resorption in orthognathic surgery: a retrospective study. J Oral Maxillofac Surg. 1991;49:448–60.PubMedCrossRefGoogle Scholar
  83. Moskowitz R, Davis W, Sammarco J, Mast W, Chase SW. Experimentally induced corticosteroid arthropathy. Arthritis Rheum. 1970;13:236–43.PubMedCrossRefGoogle Scholar
  84. Mountziaris PM, Kramer PR, Mikos AG. Emerging intra-articular drug delivery systems for the temporomandibular joint. Methods. 2009;47:134–40.PubMedCrossRefGoogle Scholar
  85. Møystad A, Mork-Knutsen BB, Bjørnland T. Injection of sodium hyaluronate compared to a corticosteroid in the treatment of patients with temporomandibular joint osteoarthritis: a CT evaluation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:e53–60.PubMedCrossRefGoogle Scholar
  86. Murakami K. Arthroscopy of the temporomandibular joint. In: Bell WH, editor. Modern practice in orthognathic and reconstructive surgery, vol. 1. Philadelphia: WB Saunders; 1992. p. 608.Google Scholar
  87. Mushtaq S, Goodman SM, Scanzello CR. Perioperative management of biologic agents used in treatment of rheumatoid arthritis. Am J Ther. 2011;18:426–34.PubMedCrossRefGoogle Scholar
  88. Narum S, Westergren T, Klemp M. Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis. BMJ Open. 2014;4:e004587.PubMedPubMedCentralCrossRefGoogle Scholar
  89. Neo H, Jun-ichi I, Kurita K, Goss AN. The effect of hyaluronic acid on experimental temporomandibular joint osteoarthrosis in sheep. J Oral Maxillofac Surg. 1997;55:1114–9.PubMedCrossRefGoogle Scholar
  90. Nicolakis P, Burak EC, Kollmitzer J, Kopf A, Piehslinger E, Wiesinger GF, Fialka-Moser V. An investigation of the effectiveness of exercise and manual therapy in treating symptoms of TMJ osteoarthritis. Cranio. 2001;19:26–32.PubMedCrossRefGoogle Scholar
  91. Niewold TB, Harrison MJ, Paget SA. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis. QJM. 2007;100:193–201.PubMedCrossRefGoogle Scholar
  92. Nitzan DW, Svidovsky J, Zini A, Zadik Y. Effect of arthrocentesis on symptomatic osteoarthritis of the temporomandibular joint and analysis of the effect of preoperative clinical and radiologic features. J Oral Maxillofac Surg. 2016;75(2):260–7. doi:10.1016/j.joms.2016.08.017.CrossRefPubMedGoogle Scholar
  93. Obeid G, Guttenberg SA, Canole PW. Costochondral grafting on condylar replacement and mandibular reconstruction. J Oral Maxillofac Surg. 1988;48:177–82.CrossRefGoogle Scholar
  94. Oh DW, Kim KS, Lee GW. The effect of physiotherapy on post-temporomandibular joint surgery patients. J Oral Rehabil. 2002;29:441–6.PubMedCrossRefGoogle Scholar
  95. Oliveira INF, Gomes RCF, dos Santos RR, Oliveira TP, Pereira LLC, Mainenti P. Gout of the temporomandibular joint: report of a case. Int Arch Otorhinolaryngol. 2014;18:316–8.PubMedPubMedCentralCrossRefGoogle Scholar
  96. Ong KL, Villarraga ML, Lau E, Carreon LY, Kurtz SM, Glassman SD. Off-label use of bone morphogenetic proteins in the United States using administrative data. Spine. 2010;35:1794–800.PubMedCrossRefGoogle Scholar
  97. Oye F, Bjornland T, Store G. Mandibular osteotomies in patients with juvenile rheumatoid arthritic disease. Scand J Rheumatol. 2003;32:168–73.PubMedCrossRefGoogle Scholar
  98. Pereira FJ, Lundh H, Westesson PL, Carlsson LE. Clinical findings related to morphologic changes in TMJ autopsy specimens. Oral Surg. 1994;78:288–95.PubMedCrossRefGoogle Scholar
  99. Perrott DH, Umeda H, Kaban LB. Costochondral graft construction/reconstruction of the ramus/condyle unit: long-term follow-up. Int J Oral Maxillofac Surg. 1994;23:321–8.PubMedCrossRefGoogle Scholar
  100. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P, International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.PubMedGoogle Scholar
  101. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15–9.PubMedPubMedCentralCrossRefGoogle Scholar
  102. Poswillo D. Experimental investigation of the effects of intra-articular hydrocortisone and high condylectomy on the mandibular condyle. Oral Surg. 1970;30:161–73.PubMedCrossRefGoogle Scholar
  103. Quinn JH, Bazan NG. Identification of prostaglandin E2 and leukotriene B4 in the synovial fluid of painful. dysfunctional temporomandibular joints. J Oral Maxillofac Surg. 1990;48:968–74.PubMedCrossRefGoogle Scholar
  104. Ringold S, Torgerson TR, Egbert MA, Wallace CA. Intraarticular corticosteroid injections of the temporomandibular joint in juvenile idiopathic arthritis. J Rheumatol. 2008;35:1157–64.PubMedGoogle Scholar
  105. Rodrigo JJ, Gershwin ME. Management of the arthritic joint. In: Chapman MW, editor. Chapman’s orthopaedic surgery. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 2551–72.Google Scholar
  106. Sacks JJ, Helmick CG, Luo Y, Ilowite NT, Bowyer S. Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001–2004. Arthritis Rheum. 2007;57:1439–45.PubMedCrossRefGoogle Scholar
  107. Saeed NR, Kent JN. A retrospective study of the costochondral graft in TMJ reconstruction. Int J Oral Maxillofac Surg. 2003;32:606–9.PubMedCrossRefGoogle Scholar
  108. Saeed NR, McLeod NMH, Hensher R. Temporomandibular joint replacement in rheumatoid-induced disease. Br J Oral Maxillofac Surg. 2001;39:71–5.PubMedCrossRefGoogle Scholar
  109. Salash JR, Hossameldin RH, Almarza AJ, Chou JC, McCain JP, Mercuri LG, Wolford LM, Detamore MS. Potential indications for tissue engineering in temporomandibular joint surgery. J Oral Maxillofac Surg. 2016;74:705–11.PubMedCrossRefGoogle Scholar
  110. Salk RS, Chang TJ, D'Costa WF, Soomekh DJ, Grogan KA. Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Joint Surg Am. 2006;88:295–302.PubMedGoogle Scholar
  111. Salter RB, Hamilton HW, Wedge JH, Tile M, Torode IP, O'Driscoll SW, Murnaghan JJ, Saringer JH. Clinical application of basic research on continuous passive motion for disorders of synovial joints. A preliminary report of a feasibility study. J Orthop Res. 1984;1:325–42.PubMedCrossRefGoogle Scholar
  112. Sánchez M, Anitua E, Azofra J, Aguirre JJ, Andia I. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol. 2008;26:910–3.PubMedGoogle Scholar
  113. Sarlos P, Kovesdi E, Magyari L, Banfai Z, Szabo A, Javorhazy A, Melegh B. Genetic update on inflammatory factors in ulcerative colitis: review of the current literature. World J Gastrointest Pathophysiol. 2014;5:304–21.PubMedPubMedCentralCrossRefGoogle Scholar
  114. Sarver D, Janyavula S. Condylar degeneration and diseases – local and systemic etiologies. Semin Orthod. 2013;19:89–96.CrossRefGoogle Scholar
  115. Shi ZD, Yang F, He ZX, Shi B, Yang MZ. Comparative study on effects of sodium hyaluronate and prednisolone injections on experimental temporomandibular joint osteoarthritis of rabbits. Chinese J Repair Reconstr Surg. 2002;16:5–10.Google Scholar
  116. Shi Z, Guo C, Awad M. Hyaluronate for temporomandibular joint disorders. Cochrane Database Syst Rev. 2003;1:CD002970.Google Scholar
  117. Sinn DP. Mandibular deficiency secondary to juvenile rheumatoid arthritis. In: Bell WH, editor. Modern practice in orthognathic and reconstructive surgery, vol. Vol 3. Philadelphia: WB Saunders; 1992. p. 2506–11.Google Scholar
  118. Slater R, Gross A, Hall J. Hydrocortisone arthropathy – an experimental investigation. Can Med Assoc J. 1967;97:374–7.Google Scholar
  119. Smyth NA, Haleem AM, Ross KA, Hannon CP, Murawski CD, Do HT, Kennedy JG. Platelet-rich plasma may improve osteochondral donor site healing in a rabbit model. Cartilage. 2016;7:104–11.PubMedPubMedCentralCrossRefGoogle Scholar
  120. Speculand B, Hensher R, Powell D. Total prosthetic replacement of the TMJ: experience with two systems 1988–1997. Br J Oral Maxillofac Surg. 2000;38:360–9.PubMedCrossRefGoogle Scholar
  121. Stafford RE. Regulating off-label drug use – rethinking the role of the FDA. N Engl J Med. 2008;358:1427–9.PubMedCrossRefGoogle Scholar
  122. Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol. 2008;4:525–33.PubMedCrossRefGoogle Scholar
  123. Statkute L, Ruderman EM. Novel TNF antagonists for the treatment of rheumatoid arthritis. Expert Opin Investig Drugs. 2010;19:105–15.PubMedCrossRefGoogle Scholar
  124. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA. 1949;140:659–62.CrossRefGoogle Scholar
  125. Stern NS, Trop RC, Balk P. Total temporomandibular joint replacement in a patient with rheumatoid arthritis: report of a case. JADA. 1986;112:491–5.PubMedGoogle Scholar
  126. Tamimi D, Hatcher D, editors. Specialty imaging. temporomandibular joint. Philadelphia: Elsevier; 2016. p. 452–3.Google Scholar
  127. Tanaka E, Detamore M, Mercuri LG. Degenerative disorders of the temporomandibular joint: etiology, diagnosis and treatment. J Dent Res. 2008;87:296–307.PubMedCrossRefGoogle Scholar
  128. Toller P. Use and misuse of intra-articular corticosteroids in the treatment of TMJ pain. Proc Soc Med. 1977;70:461–3.Google Scholar
  129. Trieger N, Hoffman CH, Rodriquez E. The effect of arthrocentesis of the temporomandibular joint in patients with rheumatoid arthritis. J Oral Maxillofac Surg. 1999;57:537–40.PubMedCrossRefGoogle Scholar
  130. US Food and Drug Administration. FDA public health advisory: safety of Vioxx. Silver Spring: FDA. 2004. Available at http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm106274.htm. Accessed 25 Sep 2015.
  131. US Food and Drug Administration. Information for healthcare professionals: Celecoxib (marketed as Celebrex). Silver Spring: FDA. 2005a. Available at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124655.htm. Accessed 25 Sep 2015. 59 US
  132. US Food and Drug Administration Information for healthcare professionals: Valdecoxib (marketed as Bextra). Silver Spring: FDA. 2005b. Available at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124649.htm. Accessed 25 Sep 2015.
  133. US Food and Drug Administration. FDA clears Cymbalta to treat chronic musculoskeletal pain. Silver Spring: FDA. 2010. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm232708.htm. Accessed 25 Sep 2015.
  134. US Food and Drug Administration. Tanezumab arthritis advisory committee briefing document. Silver Spring: FDA. 2012. Available at http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM295205.pdf. Accessed 25 Sep 2015.
  135. Vallon D, Ackerman S, Nilner M, Petersson A. Long-term follow-up of intra-articular injections into the temporomandibular joint in patients with rheumatoid arthritis. Swed Dent J. 2002;26:149–58.PubMedGoogle Scholar
  136. Verstappen SM, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, Borg EJ, Hofman DM, van der Veen MJ. Five-year follow-up of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year. Arthritis Rheum. 2003;48:1797–807.PubMedCrossRefGoogle Scholar
  137. Wang XD, Kou XX, Mao JJ, Gan YH, Zhou YH. Sustained inflammation induces degeneration of the temporomandibular joint. J Dent Res. 2012;91:499–505.PubMedPubMedCentralCrossRefGoogle Scholar
  138. Westesson PL, Rohlin M. Internal derangement related to osteoarthrosis in temporomandibular joint autopsy specimens. Oral Surg Oral Med Oral Pathol. 1984;57:17–22.PubMedCrossRefGoogle Scholar
  139. Wiesel SW, Delahay JN, editors. Essentials of orthopedic surgery. 4th ed. New York: Springer; 2011.Google Scholar
  140. Wilkes CH. Internal derangements of the temporomandibular joint. Pathological variations. Northwest Dent. 1990;69:25–32.PubMedGoogle Scholar
  141. Wolford LM. Concomitant temporomandibular joint and orthognathic surgery. J Oral Maxillofac Surg. 2003;61:1198–204.PubMedCrossRefGoogle Scholar
  142. Wolford LM, Reich-Fischel O, Mehra P. Changes in TMJ dysfunction after orthognathic surgery. J Oral Maxillofac Surg. 2002;61:655–60.CrossRefGoogle Scholar
  143. Wolford LM, Mercuri LG, Schneiderman ED, Movahed R, Allen W. Twenty-year follow-up study on a patient-fitted temporomandibular joint prosthesis: the Techmedica/TMJ concepts device. J Oral Maxillofac Surg. 2015;73:952–60.PubMedCrossRefGoogle Scholar
  144. Wright EA, Katz JN, Abrams S, Solomon DH, Losina E. Trends in prescription of opioids from 2003–2009 in persons with knee osteoarthritis. Arthritis Care Res. 2014;66:1489–95.CrossRefGoogle Scholar
  145. Zhang W, Jones A, Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomized controlled trials. Ann Rheum Dis. 2004;63:901–7.PubMedPubMedCentralCrossRefGoogle Scholar
  146. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil. 2008;16:137–62.PubMedCrossRefGoogle Scholar
  147. Zhang W, Ouyang H, Dass CR, Xu J. Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res. 2016;4:15040.PubMedPubMedCentralCrossRefGoogle Scholar
  148. Zide MF, Carlton DM, Kent JN. Rheumatoid disease and related arthropathies. I. Systemic findings, medical therapy, and peripheral joint surgery. Oral Surg. 1986;61:119–25.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Orthopedic SurgeryRush University Medical CenterChicagoUSA
  2. 2.TMJ ConceptsVenturaUSA
  3. 3.Oral and Maxillofacial Surgery and PediatricsEmory University and Children’s Healthcare of AtlantaAtlantaUSA

Personalised recommendations